Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
February 16 2021 - 5:00PM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, announced today that Paul
Bolno, MD, MBA, President and Chief Executive Officer, is scheduled
to participate in an analyst-led fireside chat at the virtual 10th
Annual SVB Leerink Global Healthcare Conference on Thursday,
February 25, 2021 at 5:00 p.m. ET.
A live webcast of the presentation will be available on the
investor relations page of the Wave Life
Sciences corporate website
at http://ir.wavelifesciences.com. A replay of the
presentation will be archived and available at that site for 90
days following the event.
About Wave Life Sciences Wave Life Sciences
(Nasdaq: WVE) is a clinical-stage genetic medicines company
committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please visit
www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2023 to Apr 2024